| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 07/08/2004 | US20040132785 Thiolesters and uses thereof |
| 07/08/2004 | US20040132782 Aspartyl protease inhibitors |
| 07/08/2004 | US20040132758 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders |
| 07/08/2004 | US20040132750 Acyl guanidine compounds and use thereof |
| 07/08/2004 | US20040132722 Glycoprotein-mediated MDR |
| 07/08/2004 | US20040132115 Method for screening compounds for alpha1B adrenergic receptor antagonist and analgesic activity |
| 07/08/2004 | US20040131969 Non-resonant two-photon absorbing material, non-resonant two-photon emitting material, method for inducing absorption of non-resonant two-photons and method for generating emission of non-resonant two-photons |
| 07/08/2004 | US20040131885 Organic electroluminescent device and organic electroluminescent compound thereof |
| 07/08/2004 | CA2800237A1 Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 07/08/2004 | CA2511360A1 Novel pharmaceuticals |
| 07/07/2004 | EP1435353A1 Novel heterocyclic compound and anti-inflammatory agent |
| 07/07/2004 | EP1435352A2 9-[(Substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines |
| 07/07/2004 | EP1434769A2 Compounds useful as reversible inhibitors of cysteine proteases |
| 07/07/2004 | EP1071670B1 Novel diphenyl-substituted 5-ring-heterocycles, method for producing them and their use as medicaments |
| 07/07/2004 | CN1511151A 3-quinoline-2-(1H)-ylideneindolin-2-one derivatives |
| 07/07/2004 | CN1511146A Preparation of taxus alkane derivative |
| 07/07/2004 | CN1510989A Insecticide and method of controlling insects |
| 07/07/2004 | CN1510032A Oxazolidone compound, preparing method and use thereof |
| 07/07/2004 | CN1156452C Compound as anti-inflammatory agent |
| 07/06/2004 | US6759554 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/06/2004 | US6759422 Administering benzothiazole compound for therapy, prophylaxis of disease |
| 07/06/2004 | US6759412 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis |
| 07/06/2004 | US6759402 Cyclic felbamate derived compounds |
| 07/06/2004 | CA2119556C Substituted aryl- and heteroaryl-phenyloxazolidinones |
| 07/01/2004 | US20040127560 compounds with high binding affinity for the glucagon receptor, such as: 3-{4-[1-(4-cyclohexylphenyl)-3-(3-trifluoromethoxyphenyl)ureidomethyl]benzoylamino}propionic acid; antidiabetic agents; antiobesity agent; antihypertensive agent |
| 07/01/2004 | US20040127527 Large conductance calcium-activated k channel opener |
| 07/01/2004 | US20040127526 elevating the HDL concentration and treating atherosclerosis and related coronary heart disease and dyslipoproteinemias |
| 07/01/2004 | US20040127513 For prophylaxis and therapy of chronic or acute inflammatory or autoimmune diseases, those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease |
| 07/01/2004 | US20040127487 For therapy and prophylaxis of bone diseases, cancer, systemic granuloma, immunological diseases, allergy, atopy, asthma, gumboil, gingivitis, periodontitis, neurocyte death, Alzheimer's diseases, lungs injury, pulmopathy, acute hepatitis |
| 07/01/2004 | US20040127426 Peptidic compounds as cysteine protease inhibitors |
| 07/01/2004 | US20040127382 activity of peroxy compounds in washing, bleaching and cleaning processes at low temperature is increased by the transition metal complexes |
| 07/01/2004 | US20040124144 In solution, suspension of a nonpolar solvent; contacting with silica; purification; decoloring |
| 07/01/2004 | DE10257786A1 Oxazolidinone Oxazolidinones |
| 06/30/2004 | EP1433786A1 Benzoxazole compound and pharmaceutical composition containing the compound |
| 06/30/2004 | EP1432690A2 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence |
| 06/30/2004 | EP1432687A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 06/30/2004 | EP1432674A2 Hydroxypropylamines |
| 06/30/2004 | EP1432420A2 Benzimidazolidinone derivatives as muscarinic agents |
| 06/30/2004 | CN1509268A Substituted aromatic amide derivative intemediate thereof, agrohorticultral insecticide containing thereof and method for use thereof |
| 06/30/2004 | CN1509173A Carboxylic and substituted oxazole derivatives for use as PPAR-& and PPAR-r activators in the treatment of diabetes |
| 06/30/2004 | CN1155593C Process for reaction of CO2 on heterocyclic compound under co-catalysis of transistion metal complex and organic alkali |
| 06/30/2004 | CN1155585C 3,5-substituted oxazolidinone derivative and its preparing process and application |
| 06/29/2004 | US6756497 Benzoic acid derivatives and processes for the preparation thereof |
| 06/29/2004 | US6756216 Batch processing using nucleophilic compound |
| 06/29/2004 | CA2171827C Use of thiazolidinediones to prevent or delay onset of niddm |
| 06/29/2004 | CA2105215C Novel oxazolidines |
| 06/24/2004 | WO2004052887A2 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 06/24/2004 | WO2004052847A2 Tricyclic steroid hormone nuclear receptor modulators |
| 06/24/2004 | WO2004052363A1 Oxazolidinones used as antiviral agents, in particular for fighting against cytomegalovirus |
| 06/24/2004 | WO2004002925A3 Process for preparing (r)-aryloxypropionic acid ester derivatives |
| 06/24/2004 | WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/24/2004 | US20040122226 Methods for preparing N-arylated oxazolidinones via a copper catalyzed cross coupling reaction |
| 06/24/2004 | US20040122069 Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals |
| 06/24/2004 | US20040122041 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof |
| 06/24/2004 | US20040122017 Melanin concentrating hormone (MCH) modulators; metabolic and eating disorders |
| 06/24/2004 | CA2508608A1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 06/23/2004 | EP1431294A1 Vascular wall-selective acat inhibitor |
| 06/23/2004 | EP1430042A2 Bicyclic heterocycles as rxr ligands |
| 06/23/2004 | EP1429765A2 Inhibitors of histone deacetylase |
| 06/23/2004 | EP1385379A4 Insecticide and method of controlling insects |
| 06/23/2004 | EP1230227B1 Benzoxa-and benzothiazolyl sulfamates and their use as steroid sulfatase inhibitors |
| 06/23/2004 | EP1036075B1 Substituted thiazolidinedione and oxazolidinedione having antidiabetic, hypolipidemia and antihypertensive properties |
| 06/23/2004 | EP1002000B1 Sprayable coating compositions comprising an oxazolidine, an isocyanate, and a mercapto functional compound |
| 06/23/2004 | CN1507446A Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors |
| 06/23/2004 | CN1154645C S-oxide and S,S-dioxide tetrahydrothiopyran phenyloxazolidinones |
| 06/23/2004 | CN1154644C Oxazolidinone derivatives and pharmaceutical compositions |
| 06/22/2004 | US6753432 Process for the preparation of thiazolidinedione derivatives |
| 06/22/2004 | US6753344 Thiophene substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
| 06/17/2004 | WO2004050667A1 Transition metal complex having diphosphine complex as ligand |
| 06/17/2004 | WO2004050613A2 2-substituted-3-propenamide derivatives and methods of using the same |
| 06/17/2004 | WO2004018414A3 Antibacterial agents |
| 06/17/2004 | US20040116711 Pesticides, drugs, fungicides; reacting p-toluenesulfony isocyanate with phosphorus oxychloride or phosgene in presence of phase transfer agent and base |
| 06/17/2004 | US20040116530 Tissue fibrosis inhibitors |
| 06/17/2004 | US20040116489 (1S*,2S*,4S*,5R*,6S*) 2-Amino-4-(3-phenylthioureido)-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid for treatment of neurological disorders and psychiatric disorders |
| 06/17/2004 | US20040116487 Novel oxazole derivatives |
| 06/17/2004 | US20040116483 Glucagon antagonists/inverse agonists |
| 06/17/2004 | US20040116445 Substituted thioacetamides |
| 06/17/2004 | US20040116404 Sulphones which modulate the action of gamma secretase |
| 06/16/2004 | EP1428818A2 Method for producing N-carbamate-protected beta-aminoepoxide and beta-aminoalcohol |
| 06/16/2004 | EP1428531A1 Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity |
| 06/16/2004 | EP1427711A1 Oxazolidinone and/or isoxazoline derivatives as antibacterial agents |
| 06/16/2004 | CN1505607A Peptide-deformylase inhibitors |
| 06/16/2004 | CN1504464A 2,5-substituted benzoxazole derivative, preparing process and uses thereof |
| 06/16/2004 | CN1153759C Novel delta-amino-gamma-hydroxy-omega-aryl-alkane amide compounds |
| 06/15/2004 | US6750255 Calcium receptor-active compounds |
| 06/15/2004 | US6750237 Pharmaceutical formulations containing zolmitriptan |
| 06/15/2004 | US6750236 Cardiovascular disorders |
| 06/15/2004 | US6749978 Electrophotographic organophotoreceptors with novel charge transport compounds |
| 06/10/2004 | WO2004047744A2 3-heterocyclic benzylamide derivatives as potassium channel openers |
| 06/10/2004 | WO2004024061A3 Aryl-link-aryl substituted thiazolidine-dione and oxazolidine-dione as sodium channel blockers |
| 06/10/2004 | US20040110961 by cyclizing alpha-isocyanoalkanoates; preparing pyridoxine derivatives |
| 06/10/2004 | US20040110945 Very Late Antigen (Vla-4); such as 4-((4S)-fluoro-1-(2-phenylamino-6-benzoxazolylacetyl)-(2S)-pyrrolidinylmethoxy)benzoic acid; for treatment of inflammatory diseases, autoimmune diseases, metastasis, bronchial asthma, rhinostenosis, and diabetes |
| 06/10/2004 | US20040110832 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc |
| 06/10/2004 | US20040110811 3-carbonyl- and sulfonyl derivatives: e.g., 1-Benzyl-3-naphthylcarbonyl-5,5-diphenylimidazolidine -2,4-dione; chymase and/or tryptase inhibition activity; especially treating chorioretinopathy, glaucoma, myopia or asthenopia. |
| 06/10/2004 | US20040110808 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 06/10/2004 | US20040110753 Tyrosine derivatives |
| 06/09/2004 | EP1425267A2 C2-substituted indane-1-ones and their derivatives, method for their production and their use as medicaments |
| 06/09/2004 | EP1425266A1 C2-substituted indane-1-ols and their derivatives, method for their production and their use as medicaments |
| 06/09/2004 | EP1425068A1 Systemical administration of some oxazolidinones, e.g. linezolid, for the treatment of ocular infections |
| 06/09/2004 | EP1425014A1 Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar activators |